Navigation Links
Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group

arable clinical outcomes compared to standard therapy. Specifically, in patients treated in the Angiomax alone group, the Angiomax plus GPI group and the heparin plus GPI group, respectively:

    * Death occurred in 3.8%, 4.2% and 4.4% of patients.  There was an

      observed numerical reduction (p=NS) in late mortality (after one month

      to one year) in the Angoimax alone treatment group, and


    * Composite ischemia events occurred in 16.4%, 16.5% and 16.3% of

      patients. Composite ischemia was defined as death, heart attack or

      unplanned revascularization for ischemia.

"We believe the one-year ACUITY results further substantiate Angiomax as a cornerstone therapy for the treatment of patients with ACS and add new information on treatment started in the emergency department to the wealth of data in the cardiac cath lab," said John Kelley, President and Chief Operating Officer of The Medicines Company. He said that MDCO anticipates submitting an sNDA for Angiomax for use in the treatment of patients with emergency ACS in the third quarter of 2007.

Additionally, the study found that major bleeding within 30 days following treatment increased the risk of death within one year even more than did a heart attack. The death rate among patients who suffered major bleeding compared to those who had a heart attack or neither was 12.5% vs. 8.6% vs. 3.4%, respectively. After adjusting for other variables, the risk of death for patients who had a major bleed or heart attack within 30 days following treatment was 2.89 and 2.47 times greater, respectively, than the risk for patients who did not experience either (p < 0.0001 for both comparisons).

"While heart attacks tend to happen in the hospital, we found the risk of death associated with major bleeding continues long-term," said Dr. Stone. "This makes major bleeding an even more powerful predictor of death than having a heart attack."

About ACUITY

Enrolling 1
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective Relative to Other Interferon Therapies for Multiple Sclerosis
2. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
5. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
6. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
7. Haemacure Announces Preliminary Findings of its Plasma Discard Analysis
8. EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3 Clinical Trial at 47th Annual NCDEU Meeting
9. Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune Deficiency
10. Prana Biotechnology Presents New Key Findings on PBT2
11. Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD

Post Your Comments:
(Date:11/5/2009)..., N.J., Nov. 5 Regent ACP, Custom ...ed 510k Clearance from the U.S. Food and Drug Admi... latest addition to Custom Spine,s continually exp...file anterior cervical plate system that was desig...e surgeon confidence of the plate being securely l...
(Date:11/5/2009)...AKS, Calif., Nov. 5 Amge...3 PRIME "203" trial evaluating Vectibix® (pan...(an oxaliplatin-based chemotherapy) as a first-lin... failed to meet a secondary endpoint of overall su...the trial met its primary endpoint by significantl...
(Date:11/5/2009)... N.Y., Nov. 5 A drug al...lso slow the growth of the most deadly bone cancer...e study published online today in the Internation... was found to be effective against bone cancer in ...xperiments were in animals, the cancer studied clo...
Breaking Medicine Technology:Custom Spine Receives 510k Clearance of Regent ACP 2Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 2Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 3Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 4Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 5Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 6Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 7Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 8Approved Lymphoma Drug Shows Promise in Early Tests Against Bone Cancer 2Approved Lymphoma Drug Shows Promise in Early Tests Against Bone Cancer 39 11 Responders May Be At Raised Myeloma Risk 54040 19 11 Responders May Be At Raised Myeloma Risk 54040 29 11 Responders May Be At Raised Myeloma Risk 54040 3NCCN Stresses Importance of PSA Testing in High Risk Men 54037 1NCCN Stresses Importance of PSA Testing in High Risk Men 54037 2NCCN Stresses Importance of PSA Testing in High Risk Men 54037 3NCCN Stresses Importance of PSA Testing in High Risk Men 54037 4NCCN Stresses Importance of PSA Testing in High Risk Men 54037 5Former UN Human Rights Rapporteur Offers 7 Points of Action on Iran to the UN Secretary General 54034 1Former UN Human Rights Rapporteur Offers 7 Points of Action on Iran to the UN Secretary General 54034 2
...t Accrual, DENVER, July 24 Pharmatech, Inc., a R...ted with five leading pharmaceutical,companies to ...their,clinical trials using the Just-in-Time (JIT)...ollowing disease indications: follicular Non-Hodgk...c Sarcoma, Chronic Myelogenous,Leukemia, and Non-S...
...ronext Paris: COX) today announced the top-line re... that was conducted following the completion of,th...evealed no unexpected,safety findings and efficacy...tudy, as measured by the patients, global assessme... patients, mean blood pressure was,stable for 52 w...
Other Medicine Technology:Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4
(Date:11/5/2009)...TE, N.C., Nov. 5 Southeast Anesthe...e at The Healthcare Leaders, Summit in Chile, Braz... ongoing, multi-year, continuing education event s...cal Devices & Diagnostic Group of the Johnson ...althcare quality and safety to Latin America to di...
(Date:11/5/2009)...BROKE, Bermuda, Nov. 5 A... AWH ) today reported net income of $200.6 millio...er of 2009 compared to a net,loss of $46.4 million...r of,2008. Net income for the nine months ended S... diluted share, compared to net income of,$163.8 m...
(Date:11/5/2009)... elevation was linked to coronary artery calcifica...thDay News) -- Elevated blood levels of phosphorus...e, U.S. researchers say. , They studied the lin...lcification (CAC) in nearly 900 healthy adults in ... of heart disease risk factors. CAC is an early si...
(Date:11/5/2009)... NJ/ - November 3, 2009 The Cornea and Laser Eye ...determine if an investigational corneal inlay can ... glasses. Dr. Peter Hersh, the study doctor, will... AcuFocus Corneal Inlay (ACI) is intended to impro...is the loss of near vision, and reduce dependency ...
(Date:11/5/2009)... FreedomVOICE® proposes telecommut...e H1N1 virus in the workplace and offers tips to b..., Encinitas, CA (Vocus) --...; hosted VoIP PBX , have proposed telecommuting as... virus in the workplace., , ,Whether we like it or...
Breaking Medicine News(10 mins):Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 2Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 3Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 4Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 5Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 6Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 7Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 8Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 9Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 10Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 11Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 12Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 13Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 14Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 15Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 16Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 17Health News:Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced 18Health News:Phosphorus Levels May Predict Heart Disease 2Health News:Near vision research study 2Health News:FreedomVOICE Proposes Telecommuting to Tackle the H1N1 Virus 2Health News:FreedomVOICE Proposes Telecommuting to Tackle the H1N1 Virus 3Health News:FreedomVOICE Proposes Telecommuting to Tackle the H1N1 Virus 4
...discovery about the genetics of coat color in dogs...eights and vary in our abilities to cope with stre...iversity School of Medicine reports. , The study,...s that most mammals share the same genetic mechani...
...DAP TMS S.A. (Nasdaq:,EDAP) the global leader in H...tate cancer announces that it has entered into a s...States based qualified institutional buyers,("Inve... will be delivered in the form of American Deposit...
...als of bipolar,disorder seem to be cropping up eve...on. The November 2007 issue of the Harvard Health ...out this condition., Bipolar disorder is difficul...times get overlooked. The Harvard,Health Letter no...
... following was,released today by the Center for Co... for Cancer Research (AICR) will,announce the resu...f cancer,at a Washington, DC press conference. AIC...eedom is,available to discuss the implications of ...
...arting Down syndrome infants on treadmill training...our or five months earlier than with only traditio...ity of Michigan says. , The study also suggests t...from locomotion: social skills, motor skills, adva...
...yslexia struggle to read because their brains aren... according to a brain-imaging study published this...uroscience (online October 16). The study found th...ing to the study,s first author, Nadine Gaab, PhD,...
Other Medicine News:Health News:Stanford researchers sniff out gene that gives dogs black fur 2Health News:Stanford researchers sniff out gene that gives dogs black fur 3Health News:EDAP TMS S.A. Announces $20 Million Placement to Fund US Clinical Studies 2Health News:EDAP TMS S.A. Announces $20 Million Placement to Fund US Clinical Studies 3Health News:Misconceptions About Bipolar Disorder Explained, From the Harvard Health Letter 2Health News:Treadmill training helps Down syndrome babies walk months earlier 2Health News:Sound training rewires dyslexic children's brains for reading 2Health News:Sound training rewires dyslexic children's brains for reading 3
...on launched the first generation HPLC system for t... new level of automation to HPLC and placed Tosoh ... in the United States, Tosohs seventh generation s...bA1c results in 2.2 minutes, -thalassemia testing,...
Advia WorkCell CDX Modular Automation
Cascade M Manual Coagulation Analyzer
...ated, coagulation workstation capable of performin...n true random access fashion. The system's unique ... and rapid processing of STAT samples without the ...calibrator dilutions are performed automatically, ...
Medicine Products: